Babraham offers access to bio-incubator via competition
Life science startups are invited to apply for one of up to five prizes that include a cash award and access to the Babraham Research Campus bio-incubator facilities, plus an additional programme of support from a host of experienced life science academic and commercial experts, including new strategic partner, Eli Lilly.
The objective of Accelerate@Babraham is to support the development of science concepts and the creation of new life science companies by providing access to equipped communal laboratories on short-term agreements, as well as guidance from mentors and introductions to investors.
Accelerate@Babraham complements the Babraham Research Campus’ ongoing support of the Cambridge life science cluster through the provision of access to the campus community and infrastructure without the need to be an established occupier on site.
The Accelerate@Babraham Start-ups Competition takes this concept one step further, to give new companies the chance to win up to five spaces on the Accelerate programme for a three-month period from September 2018.
Up to five competition finalists will win access to the bio-incubator facilities, including communal equipped laboratory space, flexible workspace within the Babraham Research Campus’ stimulating and supportive environment and access to its community hub which includes office, meeting and social spaces.
Finalists will also receive:-
- £20K non-dilutive funding per venture
- 1-2-1 mentoring from world-class science and business experts
- Access to the Babraham Research Campus’ highly experienced life science, healthcare, business and investor networks
- Access to Accelerate@Babraham’s top quality programme, bespoke training sessions and final Demo Day – all run by practitioners expert in life science and bio-innovation.
Eli Lilly becomes Accelerate@Babraham’s fifth strategic partner, joining AstraZeneca, MedImmune, One Nucleus and RxCelerate. Collectively the partners have committed to support Accelerate@Babraham occupiers via mentoring and entrepreneurial guidance, in addition to providing strategic guidance regarding the on-going development of the concept.
Dr Tim Luker, senior director, Emerging Technology and Innovation, Eli Lilly said: “Lilly has a long and successful history of working with key innovators and entrepreneurs.
“Through cutting-edge science, we’re trying to change the frontiers of what’s possible in medicine. We are delighted to support the Accelerate@Babraham initiative to help build long term relationships with exciting start-ups being formed in the Cambridge region, one of the great global life science clusters.”
Ventures wishing to apply to take part in Accelerate@Babraham’s Start-ups Competition, should download the competition application form and email it to accelerate [at] babraham.co.uk by midnight on 17th June 2018.
Shortlisted applicants will be notified on 21st June and will be invited to pitch in mid-July where a judging panel of business leaders will choose the successful finalists.
For more details visit www.babraham.com/accelerate-babraham/